PagodaTree Partners
Overview
PagodaTree Partners is an elite private equity fund manager focused on innovations in healthcare and technology. They integrate ESG principles into their investment philosophy and strategy. Their investors include leading fund of funds and family offices in China. The core team members are from top-tier international investment institutions and veterans in domestic and cross-border transactions, early-stage and growth capital investment, capital markets, and operations, with extensive resources and a global perspective. They concentrate on carefully selected healthcare, biotech, technology, and frontier interdisciplinary innovations with great potential and actively pursue special investment opportunities. They aim to foster long-term partnerships with entrepreneurs and create value for their investors and portfolio companies. PagodaTree Partners has offices in Beijing, Shanghai, Boston, and Seattle.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Gate Neurosciences | May 2025 | M&A | Co-investor |
| Syndeio Biosciences | May 2025 | VC Round | Co-investor |
| NextPoint Therapeutics | Jan 2023 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.